DigiPath Labs Provides Insight on Proposed Puerto Rico Medical Cannabis Law

DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc. (DIGP), recently expressed concerns that Puerto Rico’s new state-run medical cannabis policy does not include third-party safety testing, a crucial assurance to patients that their medicine is safe. In an interview with Caribbean Business journal, DigiPath Labs Chief Science Officer Cindy Orser, PhD, explains the need…

The post DigiPath Labs Provides Insight on Proposed Puerto Rico Medical Cannabis Law appeared first on Marijuana Index.